⌘K

17:12:58·1496d

SECFilingvia Quantisnow

SEC Form DEF 14A filed by Aquestive Therapeutics Inc.

ByQuantisnow·Wall Street's wire, on your screen.

AQST· Aquestive Therapeutics Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Chief Legal Officer Zalewski Thomas A. was granted 100,000 shares (SEC Form 4)
President and CEO Barber Daniel sold $35,413 worth of shares (8,257 units at $4.29), decreasing direct ownership by 1% to 660,574 units (SEC Form 4)
SVP, Regulatory Affairs Cioffi Melina covered exercise/tax liability with 1,667 shares, decreasing direct ownership by 0.61% to 273,200 units (SEC Form 4) (withholding obligation)
SEC Form 10-Q filed by Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Termination of a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits